Trade INM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
InMed Pharmaceuticals Inc. Common Shares (INM) is trading at US$1.31, up 2.66% today as of Sep 16, 13:06 EDT. The company has a market capitalisation of US$7.8M. Over the past 52 weeks, INM has traded between US$0.58 and US$2.50. On Syfe you can trade INM with $0 commission and add it to your watchlist.
| Previous close | US$1.28 |
|---|---|
| Market cap | US$7.8M |
| 52-week range | US$0.58 – US$2.50 |
| Volume | 78.97K |
| Exchange | US |
Add to Watchlist
Set Price Alert
InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Year: 2020
InMed Pharmaceuticals Amends Deal With Mentari Therapeutics
Jul 7, 7:40 AM · MT Newswires
Stay on top of INM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
